4//SEC Filing
Dulac Edward J III 4
Accession 0000950170-25-098774
CIK 0001652130other
Filed
Jul 24, 8:00 PM ET
Accepted
Jul 25, 4:05 PM ET
Size
4.8 KB
Accession
0000950170-25-098774
Insider Transaction Report
Form 4
Dulac Edward J III
EVP, Chief Financial Officer
Transactions
- Sale
Common Stock
2025-07-23$14.02/sh−7,462$104,617→ 106,062 total
Footnotes (1)
- [F1]Represents a mandatory "sell-to-cover" transaction for the purpose of satisfying the reporting person's tax withholding obligation upon the vesting of RSUs on July 22, 2025, and does not represent a volitional trade by the Reporting Person.
Documents
Issuer
Intellia Therapeutics, Inc.
CIK 0001652130
Entity typeother
Related Parties
1- filerCIK 0001821530
Filing Metadata
- Form type
- 4
- Filed
- Jul 24, 8:00 PM ET
- Accepted
- Jul 25, 4:05 PM ET
- Size
- 4.8 KB